Developing a vaccine to prevent leptospirosis
Leptospirosis Vaccine Development
This study is working on a new vaccine to help protect people from leptospirosis, a serious illness caused by bacteria, and it’s for anyone who wants to help fight this disease and stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Luna Bioscience, INC. NIH-funded |
| Lab location | 1 site (Westport, United States) |
| Project ID | NIH-10875620 on NIH RePORTER |
What this research studies
This research aims to create the first effective vaccine for leptospirosis, a serious disease caused by the Leptospira bacteria. The team at LeptoX, Inc. is focusing on specific proteins from the bacteria that can trigger a strong immune response in humans. By optimizing the vaccine's formulation and delivery, they hope to ensure it is both safe and effective. The research will involve testing these vaccine components in animal models before moving to human trials.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for leptospirosis, such as those living in endemic areas or working in occupations with potential exposure.
Not a fit: Patients who are not at risk for leptospirosis or those with existing immunity to the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a safe vaccine that significantly reduces the incidence and severity of leptospirosis in humans.
How similar studies have performed: Previous research has shown promise in developing vaccines for similar bacterial infections, indicating potential success for this approach.
Where this research is happening
Westport, United States
- Luna Bioscience, INC. — Westport, United States (Active)
Researchers
- Principal investigator: Devillers, Carla — Luna Bioscience, INC.
- Study coordinator: Devillers, Carla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.